The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and right behind them was bristol-myers Squibb who had the much weaker statin pravastatin sold originally as the brands of pratical let's study irish men who have not had a clinical event but also their LDL cholesterol is 180-190 some more FH Irish means that you're going from secondary prevention FH basically to primary benefit and lo and behold reduce virtually every effort from
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.